The global diagnostic enzymes market size was USD 5.04 billion in 2023, calculated at USD 5.29 billion in 2024 and is projected to surpass around USD 8.62 billion by 2034, expanding at a CAGR of 5% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Diagnostic Enzymes Market
5.1. COVID-19 Landscape: Diagnostic Enzymes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Diagnostic Enzymes Market, By Type
8.1. Diagnostic Enzymes Market, by Type, 2024-2034
8.1.1 MMLV RT
8.1.1.1. Market Revenue and Forecast (2024-2034)
8.1.2. Taq Polymerase
8.1.2.1. Market Revenue and Forecast (2024-2034)
8.1.3. Hot Start Taq Polymerase
8.1.3.1. Market Revenue and Forecast (2024-2034)
8.1.4. HIV RT
8.1.4.1. Market Revenue and Forecast (2024-2034)
8.1.5. RNase Inhibitors
8.1.5.1. Market Revenue and Forecast (2024-2034)
8.1.6. UNG
8.1.6.1. Market Revenue and Forecast (2024-2034)
8.1.7. PCR Master Mix
8.1.7.1. Market Revenue and Forecast (2024-2034)
8.1.8. Bst Polymerase
8.1.8.1. Market Revenue and Forecast (2024-2034)
8.1.9. T7 RNA Polymerase
8.1.9.1. Market Revenue and Forecast (2024-2034)
8.1.10. Lyophilized Polymerase
8.1.10.1. Market Revenue and Forecast (2024-2034)
8.1.11. Acid Phosphatase
8.1.11.1. Market Revenue and Forecast (2024-2034)
8.1.12. Cas9 Enzyme
8.1.12.1. Market Revenue and Forecast (2024-2034)
8.1.13. Amylase
8.1.13.1. Market Revenue and Forecast (2024-2034)
8.1.14. Alanine Aminotransferase
8.1.14.1. Market Revenue and Forecast (2024-2034)
8.1.15. Others
8.1.16.1. Market Revenue and Forecast (2024-2034)
8.1.16. Aspartate Aminotransferase
8.1.16.1. Market Revenue and Forecast (2024-2034)
8.1.17. Angiotensin Converting Enzyme
8.1.17.1. Market Revenue and Forecast (2024-2034)
8.1.18. Creatinine Kinase
8.1.18.1. Market Revenue and Forecast (2024-2034)
8.1.19. Cholinesterase
8.1.19.1. Market Revenue and Forecast (2024-2034)
8.1.20. Lactate Dehydrogenase
8.1.20.1. Market Revenue and Forecast (2024-2034)
8.1.21. Gamma GlutamylTransferase
8.1.21.1. Market Revenue and Forecast (2024-2034)
8.1.22. Glucose Oxidase/Glucose Dehydrogenase
8.1.22.1. Market Revenue and Forecast (2024-2034)
8.1.23. Renin
8.1.23.1. Market Revenue and Forecast (2024-2034)
8.1.24. Lactate Oxidase
8.1.24.1. Market Revenue and Forecast (2024-2034)
8.1.25. Urease
8.1.25.1. Market Revenue and Forecast (2024-2034)
8.1.26. Glutamate Oxidase
8.1.26.1. Market Revenue and Forecast (2024-2034)
8.1.27. Horseradish Peroxide
8.1.27.1. Market Revenue and Forecast (2024-2034)
8.1.28. Others
8.1.28.1. Market Revenue and Forecast (2024-2034)
Chapter 9. Global Diagnostic Enzymes Market, By Application
9.1. Diagnostic Enzymes Market, by Application, 2024-2034
9.1.1. Oncology
9.1.1.1. Market Revenue and Forecast (2024-2034)
9.1.2. Diabetes
9.1.2.1. Market Revenue and Forecast (2024-2034)
9.1.3. Infectious Diseases
9.1.3.1. Market Revenue and Forecast (2024-2034)
9.1.4. Cardiology
9.1.4.1. Market Revenue and Forecast (2024-2034)
9.1.5. Autoimmune Diseases
9.1.5.1. Market Revenue and Forecast (2024-2034)
9.1.6. Nephrology
9.1.6.1. Market Revenue and Forecast (2024-2034)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2024-2034)
Chapter 10. Global Diagnostic Enzymes Market, By Product Type
10.1. Diagnostic Enzymes Market, by Product Type, 2024-2034
10.1.1. Clinical Enzymes
10.1.1.1. Market Revenue and Forecast (2024-2034)
10.1.2. Molecular Enzymes
10.1.2.1. Market Revenue and Forecast (2024-2034)
Chapter 11. Global Diagnostic Enzymes Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2024-2034)
11.1.2. Market Revenue and Forecast, by Application (2024-2034)
11.1.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.1.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.1.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.1.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2024-2034)
11.2.2. Market Revenue and Forecast, by Application (2024-2034)
11.2.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.2.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.2.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.2.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2024-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2024-2034)
11.2.6.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2024-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2024-2034)
11.2.7.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2024-2034)
11.3.2. Market Revenue and Forecast, by Application (2024-2034)
11.3.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.3.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.3.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.3.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2024-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2024-2034)
11.3.6.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2024-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2024-2034)
11.3.7.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.4.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.4.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.4.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2024-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2024-2034)
11.4.6.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2024-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2024-2034)
11.4.7.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2024-2034)
11.5.4.2. Market Revenue and Forecast, by Application (2024-2034)
11.5.4.3. Market Revenue and Forecast, by Product Type (2024-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2024-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2024-2034)
11.5.5.3. Market Revenue and Forecast, by Product Type (2024-2034)
Chapter 12. Company Profiles
12.1. Sanofi Genzyme
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Codexis Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Aldevron
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F Hoffmann-La Roche Ltd
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Biocatalysts Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Amano Enzymes
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Kaneka Eurogentec
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Others
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample